Supplementary Appendix - Antecedent Immunosuppressive Therapy for Immune-Mediated Inflammatory Diseases in the Setting of a COVID-19 Outbreak

Published: 24 August 2020| Version 2 | DOI: 10.17632/hwf6mwdccj.2
Contributor:
Jesse Veenstra

Description

Supplemental figures and tables

Files

Categories

Dermatology, Immunosuppressive Therapy, Immune-Mediated Illness, COVID-19

Licence